CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3

Published:2024-01-04 Issue:2 Volume:64 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Zhong Kun¹,Luo Wenwu²,Li Nan³,Tan Xin¹,Li Yuqing¹,Yin Shiyuan¹,Huang Yuhang¹,Fang Linna¹,Ma Wei¹,Cai Yongping¹,Yin Yu²

Affiliation:

1. Department of Pathology, Anhui Medical University, Hefei, Anhui 230032, P.R. China

2. Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China

3. Department of Nephrology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China

Publisher

Spandidos Publications

Reference56 articles.

1. Epidemiology, etiology, diagnosis and treatment of prostate cancer;Daniyal;Asian Pac J Cancer Prev,2014

2. Prostate cancer genetics: Variation by race, ethnicity, and geography;Rebbeck;Semin Radiat Oncol,2017

3. Genetics and biology of prostate cancer;Wang;Genes Dev,2018

4. Progression in immunotherapy for advanced prostate cancer;Liang;Front Oncol,2023

5. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor;Biomedicine & Pharmacotherapy;2024-10

2. ULK2 suppresses ovarian cancer cell migration and invasion by elevating IGFBP3;PeerJ;2024-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP